# Stem Cells for Erectile Dysfunction Post RALP

> **NCT07048314** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **The Methodist Hospital Research Institute** · enrollment: 40 (estimated)

## Conditions studied

- Erectile Dysfunction
- Prostate Cancer

## Interventions

- **DRUG:** Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's office
- **DRUG:** Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) in the OR
- **DRUG:** Placebo in the OR
- **DRUG:** Placebo in clinic

## Key facts

- **NCT ID:** NCT07048314
- **Lead sponsor:** The Methodist Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-10
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07048314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07048314, "Stem Cells for Erectile Dysfunction Post RALP". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07048314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*